Iron Overload in Chronic Kidney Disease: Less Ferritin, More T2*MRI

被引:18
|
作者
Nashwan, Abdulqadir J. [1 ]
Yassin, Mohamed A. [2 ]
Ibrahim, Mohamed Izham Mohamed [3 ]
Abdul Rahim, Hanan F. [4 ]
Shraim, Mujahed [4 ]
机构
[1] Hamad Med Corp, Dept Nursing, Hazm Mebaireek Gen Hosp, Doha, Qatar
[2] Hamad Med Corp, Hematol & Oncol, Hamad Gen Hosp, Doha, Qatar
[3] Qatar Univ, Coll Pharm, QU Hlth, Doha, Qatar
[4] Qatar Univ, Coll Hlth Sci, Dept Publ Hlth, QU Hlth, Doha, Qatar
关键词
iron overload; T2*MRI; serum ferritin; chronic kidney disease; liver iron concentration (LIC); ANEMIA; MRI; GUIDELINES; BURDEN;
D O I
10.3389/fmed.2022.865669
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To date, there is no consensus on the most reliable marker of iron status in patients with chronic kidney disease (CKD). Serum ferritin is used routinely, although it may be a misleading marker for iron overload. The success of T2* MRI in monitoring iron overload in patients with hemoglobinopathies can be beneficial to monitoring patients with CKD.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Iatrogenic Iron Overload in a Patient With Chronic Kidney Disease: Is There a Correlation Between Serum Ferritin and Liver Iron Concentration Determined by MRI T2*?
    Ali, Mohammad
    Okar, Lina
    Iqbal, Phool
    Yassin, Mohamed A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [2] The Superiority of T2*MRI Over Serum Ferritin in the Evaluation of Secondary Iron Overload in a Chronic Kidney Disease Patient: A Case Report
    Al-Mashdali, Abdulrahman
    Alyafei, Tahiya
    Yassin, Mohamed
    JOURNAL OF BLOOD MEDICINE, 2021, 12 : 665 - 670
  • [3] Serum Ferritin versus T2*MRI for Estimation of Iron Overload in Children Treated for Hematological Malignancies
    Munikoty, V.
    Bansal, D.
    Sodhi, K. S.
    Bhatia, A.
    Bhatia, P.
    Attri, S. V.
    Rohit, M. K.
    Trehan, A.
    Khandelwal, N.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S690 - S691
  • [4] Iron Overload in Patients With Heavily Transfused Sickle Cell Disease-Correlation of Serum Ferritin With Cardiac T2*MRI (CMRTools), Liver T2*MRI, and R2-MRI (Ferriscan®)
    Alkindi, Salam
    Panjwani, Vinodh
    Al-Rahbi, Sarah
    Al-Saidi, Khalid
    Pathare, Anil, V
    FRONTIERS IN MEDICINE, 2021, 8
  • [5] T2*magnetic resonance imaging is more sensitive than histology and serum ferritin for the assessment of iron overload in patients with NAFLD
    Pavlides, Michael
    Banerjee, Rajarshi
    Tunnicliffe, Elizabeth M.
    Wang, Lai Mun
    Ryan, John D.
    Cobbold, Jeremy F.
    Neubauer, Stefan
    Barnes, Eleanor
    HEPATOLOGY, 2014, 60 : 729A - 729A
  • [6] Estimation of iron overload with T2*MRI in children treated for hematological malignancies
    Munikoty, Vinay
    Sodhi, Kushaljit Singh
    Bhatia, Anmol
    Bhatia, Prateek
    Verma Attri, Savita
    Rohit, Manoj K.
    Trehan, Amita
    Khandelwal, Niranjan
    Bansal, Deepak
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2023, 40 (04) : 315 - 325
  • [7] Iron overload in hemodialysis patients: Comparison of serum iron parameters with T2*MRI sequence
    Delibas, Deniz
    Evrimler, Sehnaz
    Ercan, Karabekir
    Gumus, Mehmet
    Sariyildirim, Abdullah
    Arslan, Halil
    JOURNAL OF CLINICAL ULTRASOUND, 2024, 52 (02) : 124 - 130
  • [8] Can we measure iron overload in the heart using in vivo MRI T2*?
    Taigang He
    John-Paul Carpenter
    Sutipong Jongjirasiri
    Jiraporn Laothamatas
    Suthat Fucharoen
    David Firmin
    Dudley Pennell
    Journal of Cardiovascular Magnetic Resonance, 11 (Suppl 1)
  • [9] T2*map at cardiac MRI reveals incidental hepatic and cardiac iron overload
    Brendel, Jan M.
    Kratzenstein, Alina
    Berger, Josephine
    Hagen, Florian
    Nikolaou, Konstantin
    Gawaz, Meinrad
    Greulich, Simon
    Krumm, Patrick
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2023, 104 (11) : 552 - 559
  • [10] Evaluation of cardiac iron overload by cardiac MRI T2 in regularly transfused MDS
    Pascal, L.
    Rose, C.
    Fenaux, P.
    Ernst, O.
    Chiavassa, H.
    Beyne-Rauzy, O.
    Brechignac, S.
    Balkaran, S.
    Senechal, Q.
    LEUKEMIA RESEARCH, 2009, 33 : S109 - S109